Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Busulfan × Sarcoma × Clear all

Phase

Status

Completed 29 Terminated 7 Unknown 3 Active not recruiting 2 Withdrawn 1 No longer available 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 10 Myeloid 7 Lymphoid 6 Plasma cell 2 Classical hematology 2 CNS 2 Thoracic 1 Sarcoma 1 Genitourinary 1 Dermatologic 1 Breast 1

Conditions

Sarcoma, Ewing 1

Interventions

Cyclophosphamide 9 Radiotherapy 7 pazopanib 5 Temozolomide 5 Magnetic Resonance Spectroscopy 5 Filgrastim 5 Vincristine 4 Gemcitabine 4 Etoposide 4 Doxorubicin 4 Docetaxel 4 Carboplatin 4 Biopsy 4 pembrolizumab 3 Taxes 3 Specimen Handling 3 Radiation 3 Paclitaxel 3 Nivolumab 3 Irinotecan 3 Drug Therapy 3 niraparib 2 liposomal doxorubicin 2 fludarabine phosphate 2 fludarabine 2 brigimadlin 2 Trastuzumab 2 Trabectedin 2 Surgical Procedures, Operative 2 Rituximab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01969942 2017-05-09

ASCT

University of Louisville

Phase 1 Withdrawn

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡